An exosome lysis reagent and an exosome PD-L1 protein detection kit

By using exosome lysis reagents and magnetic bead coupling reagents, combined with chemiluminescent markers, the problem of low sensitivity and specificity of exosome PD-L1 protein detection in the prior art is solved, and plasma exosome PD is achieved - Accurate detection of L1 protein.

CN114295826BActive Publication Date: 2024-11-19SHANGHAI SIDI MEDICAL LAB CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202111583122.4
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2021-12-22
Publication Date
2024-11-19
Estimated Expiration
2041-12-22

AI Technical Summary

Technical Problem

In the prior art, the sensitivity and specificity of exosome PD-L1 protein detection is low, making it difficult to accurately detect PD-L1 protein in exosomes in plasma, resulting in inaccurate detection results.

Method used

Using an exosome cleavage agent, including trimethylolamide, sodium chloride, glycerol and NP-40, combined with magnetic bead-CD63 coupling reagent and magnetic bead-PD-L1 antibody, through chemiluminescent markers Detection to improve the sensitivity and specificity of the detection.

Benefits of technology

Sensitive detection of total PD-L1 protein in plasma exosomes is achieved, which can accurately reflect the expression of PD-L1 protein in plasma exosomes at a lower sample size to be tested, and improve the accuracy and efficiency of the detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN114295826B_ABST
    Figure CN114295826B_ABST
Patent Text Reader

Abstract

The present invention discloses an exosome lysis reagent and an exosome PD-L1 protein detection kit. The exosome lysis reagent includes 3.47-4.35 g / L tris(hydroxymethyl)aminomethane, 5.8-7.1 g / L sodium chloride, 1-5% by volume glycerol, 0.5-4% by volume NP-40, 0.01-0.5 M citrate, and the solvent is water. The exosome PD-L1 protein detection kit includes an exosome lysis reagent, a magnetic bead-CD63 coupling reagent, a magnetic bead-PD-L1 antibody 1 coupling reagent, a chemiluminescent marker-PD-L1 antibody 2 coupling reagent, and an excitation solution. The present invention proposes an exosome protein detection system, which uses an exosome lysis reagent to fully lyse the exosomes after separation and purification of the exosomes, so that the exosomes can be fully lysed and efficiently react with antibodies and antigens, while not affecting subsequent chemiluminescent detection. The kit provided by the present invention can detect the total PD-L1 protein in plasma exosomes, which is more accurate than the kit product that only detects the PD-L1 protein in the exosome membrane.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention belongs to the technical field of exosome detection, and specifically relates to an exosome lysis reagent and an exosome PD-L1 protein detection kit. Background Art

[0002] Exosomes are extracellular vesicles with a lipid bilayer membrane structure. They are produced by budding from the cell membrane through a series of regulatory processes such as "endocytosis-fusion-excretion" of the cell, and their diameter is 30-200nm. In the past 10 years, scientists and researchers from many countries have conducted intensive research on exosomes, and discovered many biological functions of exosomes, and also discovered many tumor-related proteins. These proteins have positive reference value for scientific research, tumor disease progression and prevention and control.

[0003] Studies have shown that exosomes contain many contents, such as DNA, mRNA, lncRNA, circRNA, microRNA, and a variety of proteins. Studies have shown that exosomes in the plasma of tumor patients contain many proteins related to tumor development and tumor metastasis. There are intramembrane proteins and transmembrane proteins among the proteins. According to their functions, they also include many proteins that can be used for clinical drug guidance, such as PD-L1 protein, ALK protein, HER2 protein, etc. Since these proteins are mainly identified by immunohistochemical detection of tumor tissues in clinical practice, there are few studies on their expression detection in plasma exosomes. However, compared with the trauma and difficulty of tumor tissue detection, the non-invasiveness and repeatability of plasma exosome protein detection have great advantages, so it also has great development value.

[0004] Currently, there are relatively few detection products for detecting exosome PD-L1 protein on the market. Most of them are coupled to exosomes through magnetic beads, and then PD-L1 antibodies are coupled with dyes with chemiluminescent signals to bind to PD-L1 proteins on the surface of exosomes. During the detection, luminescent liquid is added to induce luminescence and the luminescence value is measured.

[0005] The current methods for detecting exosomal PD-L1 protein have the following disadvantages:

[0006] Detection of PD-L1 protein on the surface of exosomes by magnetic beads: This method only uses a PD-L1 antibody coupled with a fluorescent dye to detect PD-L1 protein on the surface of plasma exosomes. Since the content of PD-L1+ exosomes in plasma is not high, this method can only detect PD-L1 protein on the surface of exosome membranes, which will miss a large number of PD-L1 proteins in exosomes. The detection sensitivity is limited, and there will be a situation where positive plasma exosome PD-L1 protein cannot be detected. Therefore, how to use a smaller amount of plasma samples to obtain more accurate test results and improve the sensitivity and specificity of the test is a problem that needs to be solved in the current scientific research field. Summary of the invention

[0007] The purpose of the present invention is to provide an exosome lysis reagent and an exosome PD-L1 protein detection kit, which mainly solves the technical problem of low sensitivity and specificity of exosome PD-L1 protein detection in the prior art.

[0008] The technical solution adopted by the present invention to solve the above technical problems is as follows:

[0009] An exosome lysis reagent comprises: 3.47-4.35 g / L tris(hydroxymethyl)aminomethane, 5.8-7.1 g / L sodium chloride, 1-5% by volume glycerol, 0.5-4% by volume NP-40, and 0.01-0.5 M citrate solvent is water.

[0010] As a preferred embodiment, the lysis reagent includes 4.05 g / L tris(hydroxymethyl)aminomethane, 6.2 g / L sodium chloride, 2.5% glycerol, 1% NP-40, and 0.03 M citrate.

[0011] The present invention also provides an exosome PD-L1 protein detection kit, which comprises the exosome lysis reagent.

[0012] As a preferred embodiment, the kit further comprises: magnetic beads-CD63 coupling reagent, magnetic beads-PD-L1 antibody 1 coupling reagent, chemiluminescent marker-PD-L1 antibody 2 coupling reagent, and excitation solution.

[0013] As a preferred embodiment, the magnetic bead-CD63 coupling reagent includes: 8.2-9.15 g / L Tris, 6.05-7.88 g / L sodium chloride, 0.23-0.43 mg / mL magnetic bead-CD63 conjugate, wherein the concentration of antibody CD63 is 0.08-0.18 μg / mL, pH 7.5-8.0, and the solvent is water.

[0014] Specifically, the preparation method of the magnetic bead-CD63 coupling reagent is: 8.7 g / L Tris, 7.37 g / L sodium chloride; 0.08-0.18 μg / mL antibody CD63, 0.23-0.43 mg / mL magnetic beads, shake well to mix, shake and incubate at 37°C for 15 minutes to prepare the coupling reagent.

[0015] As a preferred embodiment, the magnetic bead-PD-L1 antibody 1 coupling reagent includes: 40-60mM Tris; 0.4-0.6M sodium chloride; 0.3-0.5M sucrose; 3-5g / L BSA, 0.51-0.63mg / mL magnetic bead-PD-L1 antibody 1 conjugate, wherein the concentration of PD-L1 antibody 1 is 0.1-0.22μg / mL, pH7.5-8.0, and the solvent is water.

[0016] Specifically, the preparation method of the magnetic bead-PD-L1 antibody 1 coupling reagent is: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; antibody PD-L1 antibody 1 concentration of 0.1-0.22μg / mL; 1-3μm magnetic beads, concentration of 0.45-0.57mg / mL; fully shake and mix, shake and incubate at 37°C for 15min to prepare the coupling reagent. The concentration of magnetic bead-PD-L1 antibody 1 is 0.51-0.63mg / mL, preferably 0.57mg / mL of magnetic bead-PD-L1 antibody 1 coupling reagent.

[0017] As a preferred embodiment, the chemiluminescent marker in the chemiluminescent marker-PD-L1 antibody 2 coupling reagent is AE, and the AE-PD-L1 antibody 2 coupling reagent includes: 4.5-7g / L sodium dihydrogen phosphate, 3-4g / L disodium hydrogen phosphate, 5-7g / L sodium chloride, 0.1-0.3g / L F-127, 0.64-0.82 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.0-6.5, solvent is water.

[0018] Specifically, the preparation method of the AE-PD-L1 antibody 2 coupling reagent is as follows: (1) dissolving the PD-L1 protein antibody 2 with NaHCO3 buffer; preferably, the pH of the NaHCO3 buffer is 8.3-9.0; (2) adding 9-14 times the mass concentration of acridinium ester; preferably, adding 11 times the mass concentration of acridinium ester; (3) balancing the desalting purification column with a buffer of pH 7.0-7.5; filtering out the free acridinium ester with a desalting purification column. (4) diluting the AE-PD-L1 antibody 2 conjugate obtained by filtration with a PD-L1 protein working solution buffer, the buffer system of which is 4.5-7 g / L sodium dihydrogen phosphate, 3-4 g / L sodium dihydrogen phosphate, 5-7 g / L sodium chloride, 0.1-0.3 g / L F-127, pH 6.0-6.5, solvent is water; obtain AE-PD-L1 antibody 2 conjugate reagent with pH 6.0-6.5. The concentration of AE-PD-L1 antibody 2 conjugate is 0.64-0.82 mg / mL, preferably 0.71 mg / mL.

[0019] As a preferred embodiment, the excitation liquid includes excitation liquid A and excitation liquid B, wherein the excitation liquid A includes 0.05-0.3% hydrogen peroxide and 0.28-0.5M HNO3 by volume, and the solvent is water; the excitation liquid B includes 0.10-0.34M sodium hydroxide and 0.2-1mL / L Tween-20, and the solvent is water.

[0020] As a preferred embodiment, the method for preparing the magnetic bead-CD63 coupling reagent comprises the following steps:

[0021] Step 1, wash the magnetic beads with washing reagent I, add washing reagent I to resuspend, gradually add NSP-SA-NHS and EDC, mix and react; after the reaction is completed, add washing reagent I to wash away excess activator and cross-linking agent, and then resuspend with washing reagent I;

[0022] Step 2, add anti-CD63 antibody and mix well for reaction; after the reaction is completed, add washing reagent II for washing, then wash with washing reagent III, then add washing reagent III for resuspending, and mix well overnight;

[0023] Step 3, adding washing reagent IV for washing, and then resuspending with washing reagent IV to prepare magnetic bead-CD63 coupling reagent;

[0024] The washing reagent I comprises: 6.24-9.31 g / L of 2-morpholineethanesulfonic acid monohydrate, the solvent is water; preferably 8.72 g / L of 2-morpholineethanesulfonic acid monohydrate;

[0025] The washing reagent II comprises: 7.13-8.32 g / L Tris, 4.88-5.43 g / L sodium chloride, 0.2-0.5 mL / L Tween-20, and the solvent is water; preferably 7.65 g / L Tris, 5.03 g / L sodium chloride, and 0.3 mL / L Tween-20;

[0026] The washing reagent III comprises: 7.2-8.9 g / L Tris, 5.41-6.32 g / L sodium chloride, 0.2-0.5 mL / L Tween-20, and the solvent is water; preferably 7.62 g / L Tris, 5.42 g / L sodium chloride, and 0.35 mL / L Tween-20;

[0027] The washing reagent IV comprises: 8.2-9.15 g / L Tris, 6.05-7.88 g / L sodium chloride, and the solvent is water; preferably 8.7 g / L Tris, 7.37 g / L sodium chloride.

[0028] Specifically, the method for detecting the total plasma exosome PD-L1 protein expression using the kit provided by the present invention comprises the following steps:

[0029] (1) Wash 50 μL (5 mg) of magnetic beads once with 1 mL of washing reagent I.

[0030] (2) Add 900 μL of washing reagent I to (1) and resuspend, then gradually add 30 μL (7 mg / mL) of SNSP-SA-NHS and 30 μL (3 mg / mL) of EDC, and react on a mixer for 30 min.

[0031] (3) Add 1 mL of washing reagent I to (2) and wash twice to remove excess activator and cross-linker. Then resuspend with 1 mL of washing reagent I.

[0032] (4) Add 300 μg of anti-CD63 antibody to (3) (final volume 1 mL) and react on a mixer for 2-3 h.

[0033] (5) Add 1 mL of washing reagent II to (4), wash once, then wash once with 1 mL of washing reagent III, and then resuspend with 1 mL of washing reagent III and place on a homogenizer overnight.

[0034] (6) Add 1 mL of washing reagent IV to (5) and wash three times, then resuspend with 1 mL of washing reagent IV to obtain magnetic bead-CD63 coupling reagent.

[0035] (7) Take 30 μL of magnetic bead-CD63 coupling reagent, add 1 mL of 1×PBST (1×PBS, pH 7.2, add 5 mL / L Tween-20) buffer, blow and resuspend, place on a magnetic stand for magnetic separation, and remove the liquid phase after the solution is clarified.

[0036] (8) Add 200 μL of plasma and 352 μL of 1× PBS buffer (pH 7.2) to (7) and incubate at 37°C for 30 min.

[0037] (9) Add 1 mL of 1× PBST (pH 7.2) buffer to (8), resuspend by pipetting, and place on a magnetic stand for magnetic separation. After the solution becomes clear, remove the liquid phase and repeat the operation once more (wash twice).

[0038] (10) Add 200 μL of exosome lysis reagent to (9), mix well by pipetting, let stand for 10 min, place on a magnetic stand for magnetic separation for 5 min, and then transfer the supernatant to a new centrifuge tube.

[0039] (11) Add 10 μL of magnetic beads-PD-L1 antibody 1 coupling reagent to the centrifuge tube, pipette to resuspend, and incubate at room temperature for 20 min.

[0040] The magnetic bead-PD-L1 antibody 1 coupling reagent components include: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; PD-L1 antibody 1 concentration of 0.1-0.22μg / mL; 1-3μm magnetic microspheres, concentration of 0.45-0.57mg / mL; fully shake and mix, shake and incubate at 37°C for 15min to prepare the coupling reagent, the concentration of magnetic bead-PD-L1 antibody 1 is 0.51-0.63mg / mL, preferably 0.57mg / mL of magnetic bead-PD-L1 antibody 1 coupling reagent.

[0041] (12) Add 1 mL of PBST (PH: 7.2) buffer to (11), pipette and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice).

[0042] (13) Add 250 μL 1× PBST (PH: 7.2) buffer to (12), and resuspend by pipetting 8 μL PD-L1-AE coupling reagent, and incubate at room temperature for 20 min.

[0043] (14) Add 1 mL of 1× PBST (PH: 7.2) buffer to (13), resuspend by pipetting, and place on a magnetic stand for magnetic separation. After the solution is clarified, remove the liquid phase and repeat the operation once (wash twice).

[0044] (15) Add 250 μL of 1× PBST (PH: 7.2) buffer to (14) and resuspend by pipetting.

[0045] (16) Add 100 μL of excitation solution A to (15), react for 3 min, then add 100 μL of excitation solution B, and detect the luminescence value of exosomal PD-L1 protein at a wavelength of 430 nm.

[0046] The English abbreviations involved in the present invention are annotated as follows:

[0047] AE: Acridinium ester

[0048] SNSP-SA-NHS: Acridinium Salt

[0049] EDC: 1-ethyl-(3-dimethylaminopropyl)carbodiimide

[0050] Tris: Tris(hydroxymethyl)aminomethane

[0051] RLU: Relative Light Unit

[0052] EDTA-Na2: Ethylenediaminetetraacetic acid disodium salt

[0053] Compared with the prior art, the present invention has the following beneficial effects:

[0054] 1. The present invention proposes an exosome protein detection system. After the exosomes are separated and purified, an exosome lysis reagent is used to fully lyse the exosomes, so that the exosomes can be fully lysed and efficiently react with antibodies and antigens without affecting subsequent chemiluminescence detection. The present invention has found through experimental exploration that adding a citrate antigen repair agent to the exosome lysis reagent can significantly improve the detection sensitivity compared with other antigen repair components.

[0055] 2. The present invention screened a lysis solution formula suitable for exosome lysis, in which the citrate contained as an antibody antigen repair component can not only help the exosome lysis but also protect the protein, the antibody and the antigen components in the incubated mixed solution, so that the antibody and the antigen can be better combined, and does not affect the subsequent chemiluminescence detection, thereby helping to realize the detection of total PD-L1 protein in plasma exosomes.

[0056] 3. The present invention also screened out the formulas such as magnetic beads, the ratio of coupled antibodies, and coupling adjuvants suitable for the PD-L1 protein detection kit, so that the total PD-L1 protein expression in plasma exosomes can be detected relatively sensitively under the premise of a relatively low amount of sample to be tested, reflecting the actual expression of the total PD-L1 protein in plasma exosomes in low-amount plasma samples.

[0057] 4. Since the detection kit of the present invention uses a fixable magnetic bead system, it can automatically transfer and fix the sample to be tested, realize automated operation, and realize simultaneous detection of multiple samples. Therefore, the detection kit is sensitive, efficient, and saves labor costs and time costs. BRIEF DESCRIPTION OF THE DRAWINGS

[0058] Figure 1 It is a detection flow chart of the kit of the present invention. DETAILED DESCRIPTION

[0059] The technical solution of the present invention is described in detail below in conjunction with the embodiments. The reagents and biological materials used below are all commercial products unless otherwise specified.

[0060] Example 1: Detection of PD-L1 protein expression in PD-L1+ and PD-L1- plasma exosomes

[0061] The specific components of the test kit used are as follows:

[0062] Exosome lysis reagent components: 4.05 g / L tris(hydroxymethyl)aminomethane, 6.2 g / L sodium chloride, 2.5% glycerol (v / v), 1% NP-40 (v / v), 0.03 M citrate, and the solvent is water.

[0063] Components of the magnetic bead-CD63 coupling reagent: 8.7 g / L Tris, 7.37 g / L sodium chloride; 0.35 mg / mL magnetic bead-CD63 coupling reagent, the solvent is water.

[0064] Components of magnetic bead-PD-L1 antibody 1 coupling reagent: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; 0.57mg / mL magnetic bead-PD-L1 antibody 1 coupling reagent, the solvent is water.

[0065] AE-PD-L1 antibody 2 coupling reagent components: 5.2g / L sodium dihydrogen phosphate, 3.4g / L sodium dihydrogen phosphate, 6.1g / L sodium chloride, 0.2g / L F-127, 0.71 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.2, solvent is water.

[0066] Component A of the excitation solution: 0.1% (v / v) hydrogen peroxide and 0.38M HNO3, the solvent is water.

[0067] Components of the excitation solution B: 0.22 M sodium hydroxide and 0.9 mL / L Tween-20 (v / v), the solvent is water.

[0068] Washing reagent I component: 8.72 g / L 2-morpholineethanesulfonic acid monohydrate, the solvent is water.

[0069] Washing reagent II components: 7.65 g / L Tris, 5.03 g / L sodium chloride, 0.3 mL / L Tween-20 (v / v), the solvent is water.

[0070] Washing reagent III components: 7.62 g / L Tris, 5.42 g / L sodium chloride, 0.35 mL / L Tween-20 (v / v), the solvent is water.

[0071] Washing reagent IV components: 8.7 g / L Tris, 7.37 g / L sodium chloride, and the solvent is water.

[0072] 1× PBS buffer (PH:7.2).

[0073] 1× PBST buffer (PH:7.2).

[0074] The detection process of the kit of the present invention is as follows Figure 1 As shown, the specific detection steps are as follows:

[0075] Step 1: Centrifuge 2 mL of PD-L1+ whole blood sample and 2 mL of PD-L1- whole blood sample at 800 g for 10 min to obtain plasma samples, which are then placed in a 4°C refrigerator for later use.

[0076] Step 2: Wash 50 μL (5 mg) of magnetic beads once with 1 mL of washing reagent I. Then add 900 μL of washing reagent I to resuspend, gradually add 30 μL (7 mg / mL) of SNSP-SA-NHS and 30 μL (3 mg / mL) of EDC, and react on a mixer for 30 min.

[0077] Step 3: Add 1 mL of washing reagent I and wash twice. Resuspend with 1 mL of washing reagent I and add 300 μg of anti-CD63 antibody, and react on a mixer for 2-3 hours.

[0078] Step 4: Add 1 mL of washing reagent II to the test tube and wash once, wash once with 1 mL of washing reagent III, resuspend with 1 mL of washing reagent III, and place on a mixer overnight.

[0079] Step 5: Add 1 mL of washing reagent IV and wash three times, then resuspend with 1 mL of washing reagent IV to obtain magnetic beads-CD63 magnetic beads coupling reagent.

[0080] Step 6: Take 30 μL of magnetic bead-CD63 coupling reagent, add 1 mL of 1×PBST (PH: 7.2) buffer, blow and resuspend, place on a magnetic stand for magnetic separation, and remove the liquid phase after the solution is clarified. Prepare three test samples: PD-L1+ plasma sample, PD-L1- plasma sample, PBS control (1×PBS, PH7.2); set 5 volume gradients of 200 μL, 100 μL, 50 μL, 20 μL, and 10 μL for each group of samples (when loading the sample for detection, if the sample volume is less than 200 μL, use 1×PBS, pH7.2 buffer to make up to 200 μL), and then add 352 μL of 1×PBS (PH7.2) buffer respectively, and incubate at 37°C for 30 minutes.

[0081] Step 7: Add 1 mL of 1×PBST (PH7.2) buffer to each sample tube, resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice).

[0082] Step 8: Add 200 μL of exosome lysis reagent, pipette and mix, let stand for 10 minutes, place on a magnetic stand for magnetic separation for 5 minutes, and then transfer the supernatant to a new centrifuge tube. Add 10 μL of magnetic beads-PD-L1 antibody 1 coupling reagent to the centrifuge tube, pipette and resuspend, and incubate at room temperature for 20 minutes.

[0083] Step 9: Add 1mL 1×PBST (PH: 7.2) buffer and resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice). Add 250μL 1×PBST (PH: 7.2) buffer and 8μL AE-PD-L1 antibody 2 coupling reagent and resuspend by pipetting, and incubate at room temperature for 20min.

[0084] Step 10: Add 1 mL of 1×PBST (PH: 7.2) buffer and resuspend by pipetting. Place on a magnetic stand for magnetic separation. After the solution is clarified, remove the liquid phase and repeat the operation once (wash twice).

[0085] Step 11: Add 250 μL 1×PBST (PH: 7.2) buffer and resuspend by pipetting.

[0086] Step 12: Add 100 μL of excitation solution A, react for 3 min, then add 100 μL of excitation solution B, and detect the luminescence value of exosome PD-L1 protein at a wavelength of 430 nm. The detection data results are shown in Table 1.

[0087] Table 1

[0088]

[0089] Example 2: Screening and testing of PD-L1+ plasma exosome PD-L1 protein expression by different components of lysis reagents

[0090] The reagents used for the test are as follows:

[0091] Exosome lysis reagent components (preferred group): 4.05 g / L tris(hydroxymethyl)aminomethane, 6.2 g / L sodium chloride, 2.5% glycerol (v / v), 1% NP-40 (v / v), 0.03 M citrate (antigen repair component), and the solvent is water.

[0092] The concentrations of the three control groups were: 0.005M citrate; 0.06M citrate; 7% glycerol (v / v).

[0093] The other antigen retrieval reagents of the two groups were: 1 mM / L ethylenediaminetetraacetic acid disodium salt (EDTA-Na2), pH: 7.0, solvent is water; 0.05% trypsin (v / v), solvent is water.

[0094] Components of the magnetic bead-CD63 coupling reagent: 8.7 g / L Tris, 7.37 g / L sodium chloride; 0.35 mg / mL magnetic bead-CD63 coupling reagent, the solvent is water.

[0095] Components of magnetic bead-PD-L1 antibody 1 coupling reagent: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; 0.57mg / mL magnetic bead-PD-L1 antibody 1 coupling reagent, the solvent is water.

[0096] AE-PD-L1 antibody 2 coupling reagent components: 5.2g / L sodium dihydrogen phosphate, 3.4g / L sodium dihydrogen phosphate, 6.1g / L sodium chloride, 0.2g / L F-127, 0.71 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.2, solvent is water.

[0097] Component A of the excitation solution: 0.1% (v / v) hydrogen peroxide and 0.38M HNO3, the solvent is water.

[0098] Components of the excitation solution B: 0.22 M sodium hydroxide and 0.9 mL / L Tween-20 (v / v), the solvent is water.

[0099] Washing reagent I component: 8.72 g / L 2-morpholineethanesulfonic acid monohydrate, the solvent is water.

[0100] Washing reagent II components: 7.65 g / L Tris, 5.03 g / L sodium chloride, 0.3 mL / L Tween-20 (v / v), the solvent is water.

[0101] Washing reagent III components: 7.62 g / L Tris, 5.42 g / L sodium chloride, 0.35 mL / L Tween-20 (v / v), the solvent is water.

[0102] Washing reagent IV components: 8.7 g / L Tris, 7.37 g / L sodium chloride, and the solvent is water.

[0103] 1× PBS buffer (PH:7.2).

[0104] 1× PBST buffer (PH:7.2).

[0105] Step 1: 3 mL of PD-L1+ whole blood sample was centrifuged at 800 g for 10 min to obtain plasma samples, which were placed in a 4°C refrigerator for later use. Subsequent experiments were divided into 5 test methods, and 2 parallel groups were set up for each method for testing.

[0106] Step 2: Wash 50 μL (5 mg) of magnetic beads once with 1 mL of washing reagent I. Then add 900 μL of washing reagent I to resuspend, gradually add 30 μL (7 mg / mL) of SNSP-SA-NHS and 30 μL (3 mg / mL) of EDC, and react on a mixer for 30 min.

[0107] Step 3: Add 1 mL of washing reagent I and wash twice. Resuspend with 1 mL of washing reagent I and add 300 μg of anti-CD63 antibody, and react on a mixer for 2-3 hours.

[0108] Step 4: Add 1 mL of washing reagent II to the test tube and wash once, wash once with 1 mL of washing reagent III, resuspend with 1 mL of washing reagent III, and place on a mixer overnight.

[0109] Step 5: Add 1 mL of washing reagent IV and wash three times, then resuspend with 1 mL of washing reagent IV to obtain the magnetic bead-CD63 coupling reagent.

[0110] Step 6: Take 30μL of magnetic bead-CD63 coupling reagent, add 1mL 1×PBST (PH: 7.2) buffer, blow and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified. Add 200μL plasma and 352μL 1×PBS (PH: 7.2) buffer, incubate at 37℃ for 30min. Prepare 10 test samples.

[0111] Step 7: Add 1 mL of 1×PBST (PH: 7.2) buffer to the test tube, pipette and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice).

[0112] Step 8: Exosome lysis reagents prepared under 6 different test conditions (preferred group formula, 0.005M citrate, 0.06M citrate, 7% glycerol (v / v), 1mM / L ethylenediaminetetraacetic acid disodium salt (EDTA-Na2) pH7.0, 0.05% trypsin (v / v), in two parallel groups, pipetted and mixed, placed on a magnetic stand for magnetic separation for 5 minutes after standing for 10 minutes, and then the supernatant was transferred to a new centrifuge tube. 10μL of magnetic beads-PD-L1 antibody 1 coupling reagent was added to the centrifuge tube, resuspended by pipetting, and incubated at room temperature for 20 minutes.

[0113] Step 9: Add 1mL 1×PBST (PH: 7.2) buffer and resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice). Add 250μL 1×PBST (PH: 7.2) buffer and 8μL AE-PD-L1 antibody 2 coupling reagent and resuspend by pipetting, and incubate at room temperature for 20min.

[0114] Step 10: Add 1 mL of 1×PBST (PH: 7.2) buffer and resuspend by pipetting. Place on a magnetic stand for magnetic separation. After the solution is clarified, remove the liquid phase and repeat the operation once (wash twice).

[0115] Step 11: Add 250 μL 1×PBST (PH: 7.2) buffer and resuspend by pipetting.

[0116] Step 12: Add 100 μL of excitation solution A, react for 3 min, then add 100 μL of excitation solution B, and detect the luminescence value of exosome PD-L1 protein at a wavelength of 430 nm. The test results are shown in Table 2.

[0117] Table 2

[0118]

[0119] NP-40 is the main lysate component of exosomes. When lysing exosomes, it will have a certain denaturing effect on the proteins in the exosomes, thereby having a certain impact on the fluorescence signal of the subsequent chemiluminescence detection. Therefore, certain antigen repair components are added during lysis to improve the sensitivity of chemiluminescence detection. The selected antigen repair component needs to have a strong antigen repair function, slow volatility, and will not oxidize during the reaction process. Based on the above requirements, several selected antigen repair components (0.03M citrate; 1mM / L disodium ethylenediaminetetraacetic acid (EDTA-Na2) (PH: 7.0); 0.05% trypsin (v / v)) were tested.

[0120] The data in Table 2 show that the test results of the preferred formula of the exosome lysis reagent of the present invention show that the test effect of the preferred formula is significantly higher than the test effects of other components.

[0121] Example 3: Detection of PD-L1 protein expression in plasma exosomes using different lysis reagents

[0122] The reagents used for the test are as follows:

[0123] Exosome lysis reagent components: 4.05 g / L tris(hydroxymethyl)aminomethane, 6.2 g / L sodium chloride, 2.5% glycerol (v / v), 1% NP-40 (v / v), 0.03 M citrate (optional), and the solvent is water.

[0124] Commercial protein lysis buffer (control reagent): PIERCE RAPI Buffer (Thermo, catalog number: 89900).

[0125] Components of the magnetic bead-CD63 coupling reagent: 8.7 g / L Tris, 7.37 g / L sodium chloride; 0.35 mg / mL magnetic bead-CD63 coupling reagent, the solvent is water.

[0126] Components of magnetic bead-PD-L1 antibody 1 coupling reagent: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; 0.57mg / mL magnetic bead-PD-L1 antibody 1 coupling reagent, the solvent is water.

[0127] AE-PD-L1 antibody 2 coupling reagent components: 5.2g / L sodium dihydrogen phosphate, 3.4g / L sodium dihydrogen phosphate, 6.1g / L sodium chloride, 0.2g / L F-127, 0.71 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.2, solvent is water.

[0128] Component A of the excitation solution: 0.1% (v / v) hydrogen peroxide and 0.38M HNO3, the solvent is water.

[0129] Components of the excitation solution B: 0.22 M sodium hydroxide and 0.9 mL / L Tween-20 (v / v), the solvent is water.

[0130] Washing reagent I component: 8.72 g / L 2-morpholineethanesulfonic acid monohydrate, the solvent is water.

[0131] Washing reagent II components: 7.65 g / L Tris, 5.03 g / L sodium chloride, 0.3 mL / L Tween-20 (v / v), the solvent is water.

[0132] Washing reagent III components: 7.62 g / L Tris, 5.42 g / L sodium chloride, 0.35 mL / L Tween-20 (v / v), the solvent is water.

[0133] Washing reagent IV components: 8.7 g / L Tris, 7.37 g / L sodium chloride, and the solvent is water.

[0134] 1× PBS buffer (PH:7.2).

[0135] 1× PBST buffer (PH:7.2).

[0136] Step 1: 2 mL of PD-L1+ whole blood sample was centrifuged at 800 g for 10 min to obtain plasma samples, which were placed in a 4°C refrigerator for later use. Subsequent experiments were divided into three test methods, with two parallel groups set up for each method.

[0137] Step 2: Wash 50 μL (5 mg) of magnetic beads once with 1 mL of washing reagent I. Then add 900 μL of washing reagent I to resuspend, gradually add 30 μL (7 mg / mL) of SNSP-SA-NHS and 30 μL (3 mg / mL) of EDC, and react on a mixer for 30 min.

[0138] Step 3: Add 1 mL of washing reagent I and wash twice. Resuspend with 1 mL of washing reagent I and add 300 μg of anti-CD63 antibody, and react on a mixer for 2-3 hours.

[0139] Step 4: Add 1 mL of washing reagent II to the test tube and wash once, wash once with 1 mL of washing reagent III, resuspend with 1 mL of washing reagent III, and place on a mixer overnight.

[0140] Step 5: Add 1 mL of washing reagent IV and wash three times, then resuspend with 1 mL of washing reagent IV to obtain the magnetic bead-CD63 coupling reagent.

[0141] Step 6: Take 30μL of magnetic bead-CD63 coupling reagent, add 1mL 1×PBST (PH: 7.2) buffer, blow and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified. Add 200μL plasma and 352μL 1×PBS (PH: 7.2) buffer, incubate at 37℃ for 30min. Prepare 6 test samples.

[0142] Step 7: Add 1 mL of 1×PBST (PH: 7.2) buffer to the test tube, pipette and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice).

[0143] Step 8: Three exosome lysis reagents were tested, and 200 μL of commercial protein lysis buffer (PIERCERAPI Buffer, Thermo, catalog number: 89900), the exosome lysis reagent of the present invention (without citrate), and the exosome lysis reagent of the present invention (with citrate) were added to two parallel groups, mixed by pipetting, and placed on a magnetic stand for magnetic separation for 5 minutes after standing for 10 minutes, and then the supernatant was transferred to a new centrifuge tube. 10 μL of magnetic beads-PD-L1 antibody 1 coupling reagent was added to the centrifuge tube, resuspended by pipetting, and incubated at room temperature for 20 minutes.

[0144] Step 9: Add 1mL 1×PBST (PH: 7.2) buffer and resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice). Add 250μL 1×PBST (PH: 7.2) buffer and 8μL AE-PD-L1 antibody 2 coupling reagent and resuspend by pipetting, and incubate at room temperature for 20min.

[0145] Step 10: Add 1 mL of 1×PBST (PH: 7.2) buffer and resuspend by pipetting. Place on a magnetic stand for magnetic separation. After the solution is clarified, remove the liquid phase and repeat the operation once (wash twice).

[0146] Step 11: Add 250 μL 1×PBST (PH: 7.2) buffer and resuspend by pipetting.

[0147] Step 12: Add 100 μL of excitation solution A, react for 3 min, then add 100 μL of excitation solution B, and detect the luminescence value of exosome PD-L1 protein at a wavelength of 430 nm. The test results are shown in Table 3.

[0148] Table 3

[0149]

[0150] The data in Table 3 show that the detection sensitivity of the exosome lysis reagent of the present invention is significantly higher than that of the commercial exosome lysis reagent. In addition, the addition of antibody antigen repair solution (citrate) will further improve the detection sensitivity of the exosome lysis reagent.

[0151] Example 4: Comparison of AE-PD-L1 products from other vendors and the PD-L1 protein detection kit of the present invention in detecting PD-L1+ plasma exosome PD-L1 protein expression

[0152] Reagents used in the test:

[0153] AE-PD-L1 products from other merchants (Cloud-Clone, item number: SCA788Hu)

[0154] The components of the exosome lysis reagent of this patent are: 4.05g / L tris(hydroxymethyl)aminomethane, 6.2g / L sodium chloride, 2.5% glycerol (v / v), 1% NP-40 (v / v), 0.03M citrate, and the solvent is water.

[0155] Components of the magnetic bead-CD63 coupling reagent: 8.7 g / L Tris, 7.37 g / L sodium chloride; 0.35 mg / mL magnetic bead-CD63 coupling reagent, the solvent is water.

[0156] Components of magnetic bead-PD-L1 antibody 1 coupling reagent: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; 0.57mg / mL magnetic bead-PD-L1 antibody 1 coupling reagent, the solvent is water.

[0157] AE-PD-L1 antibody 2 coupling reagent components: 5.2g / L sodium dihydrogen phosphate, 3.4g / L sodium dihydrogen phosphate, 6.1g / L sodium chloride, 0.2g / L F-127, 0.71 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.2, solvent is water.

[0158] Component A of the excitation solution: 0.1% (v / v) hydrogen peroxide and 0.38M HNO3, the solvent is water.

[0159] Components of the excitation solution B: 0.22 M sodium hydroxide and 0.9 mL / L Tween-20 (v / v), the solvent is water.

[0160] Washing reagent I component: 8.72 g / L 2-morpholineethanesulfonic acid monohydrate, the solvent is water.

[0161] Washing reagent II components: 7.65 g / L Tris, 5.03 g / L sodium chloride, 0.3 mL / L Tween-20 (v / v), the solvent is water.

[0162] Washing reagent III components: 7.62 g / L Tris, 5.42 g / L sodium chloride, 0.35 mL / L Tween-20 (v / v), the solvent is water.

[0163] Washing reagent IV components: 8.7 g / L Tris, 7.37 g / L sodium chloride, and the solvent is water.

[0164] 1× PBS buffer (PH:7.2).

[0165] 1× PBST buffer (PH:7.2).

[0166] Step 1: Centrifuge two 2 mL PD-L1+ whole blood samples at 800 g for 10 min to obtain plasma samples, which are placed in a 4°C refrigerator for later use. Subsequent experiments are divided into two test methods for detection.

[0167] Step 2: Wash 50 μL (5 mg) of magnetic beads once with 1 mL of washing reagent I. Then add 900 μL of washing reagent I to resuspend, gradually add 30 μL (7 mg / mL) of SNSP-SA-NHS and 30 μL (3 mg / mL) of EDC, and react on a mixer for 30 min.

[0168] Step 3: Add 1 mL of washing reagent I and wash twice. Resuspend with 1 mL of washing reagent I and add 300 μg of anti-CD63 antibody. React on a mixer for 2-3 hours.

[0169] Step 4: Add 1 mL of washing reagent II to the test tube and wash once, wash once with 1 mL of washing reagent III, resuspend with 1 mL of washing reagent III, and place on a mixer overnight.

[0170] Step 5: Add 1 mL of washing reagent IV and wash three times, then resuspend with 1 mL of washing reagent IV to obtain the magnetic bead-CD63 coupling reagent.

[0171] Step 6: Take 30 μL of magnetic bead-CD63 coupling reagent, add 1 mL of 1×PBST (PH: 7.2) buffer, blow and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified. Add 200 μL of plasma and 352 μL of 1×PBS (PH: 7.2) buffer, and incubate at 37°C for 30 min.

[0172] Step 7: Add 1 mL of 1×PBST (PH: 7.2) buffer to the test tube, pipette and resuspend, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice). (The commercial control product anti-PD-L1 antibody group does not need to add lysis reagent, and proceed directly to step 9)

[0173] Step 8: Add 200 μL of exosome lysis solution A, pipette and mix, let stand for 10 minutes, place on a magnetic stand for magnetic separation for 5 minutes, and then transfer the supernatant to a new centrifuge tube. Add 10 μL of magnetic beads-PD-L1 antibody 1 coupling reagent to the centrifuge tube, pipette and resuspend, and incubate at room temperature for 20 minutes.

[0174] Step 9: Add 1mL 1×PBST (PH: 7.2) buffer, resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice). Correspondingly, add 250μL 1×PBST (PH: 7.2) buffer, 8μL AE-PD-L1 antibody 2 coupling reagent, resuspend by pipetting, and incubate at room temperature for 20min. Or add 8μL AE-PD-L1 (Cloud-Clone, catalog number: SCA788Hu) from other vendors to the control group, resuspend by pipetting, and incubate at room temperature for 20min.

[0175] Step 10: Add 1 mL of 1×PBST (PH: 7.2) buffer and resuspend by pipetting. Place on a magnetic stand for magnetic separation. After the solution is clarified, remove the liquid phase and repeat the operation once (wash twice).

[0176] Step 11: Add 250 μL 1×PBST (PH: 7.2) buffer and resuspend by pipetting.

[0177] Step 12: Add 100 μL of excitation solution A, react for 3 min, then add 100 μL of excitation solution B, and detect the luminescence value of exosome PD-L1 protein at a wavelength of 430 nm. The results are shown in Table 4. The results in Table 4 show that the PD-L1 protein detection kit provided by the present invention has significantly improved detection sensitivity compared with existing products on the market.

[0178] Table 4

[0179]

[0180] Example 5: The lysate end value of the patented detection kit tests the expression of PD-L1+ plasma exosome PD-L1 protein

[0181] Reagents used in the test:

[0182] Exosome lysis reagent component A: 3.47 g / L tris(hydroxymethyl)aminomethane, 5.8 g / L sodium chloride, 1% glycerol (v / v), 0.5% NP-40 (v / v), 0.01 M citrate, and the solvent is water.

[0183] Exosome lysis reagent B component: 4.35 g / L tris(hydroxymethyl)aminomethane, 7.1 g / L sodium chloride, 5% glycerol (v / v), 4% NP-40 (v / v), 0.5 M citrate, the solvent is water.

[0184] Components of the magnetic bead-CD63 coupling reagent: 8.7 g / L Tris, 7.37 g / L sodium chloride; 0.35 mg / mL magnetic bead-CD63 coupling reagent, the solvent is water.

[0185] Components of magnetic bead-PD-L1 antibody 1 coupling reagent: 50mM Tris; 0.5M sodium chloride; 0.4M sucrose; 4g / L BSA, pH7.8; 0.57mg / mL magnetic bead-PD-L1 antibody 1 coupling reagent, the solvent is water.

[0186] AE-PD-L1 antibody 2 coupling reagent components: 5.2g / L sodium dihydrogen phosphate, 3.4g / L sodium dihydrogen phosphate, 6.1g / L sodium chloride, 0.2g / L F-127, 0.71 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.2, solvent is water.

[0187] Component A of the excitation solution: 0.1% (v / v) hydrogen peroxide and 0.38M HNO3, the solvent is water.

[0188] Components of the excitation solution B: 0.22 M sodium hydroxide and 0.9 mL / L Tween-20 (v / v), the solvent is water.

[0189] Washing reagent I component: 8.72 g / L 2-morpholineethanesulfonic acid monohydrate, the solvent is water.

[0190] Washing reagent II components: 7.65 g / L Tris, 5.03 g / L sodium chloride, 0.3 mL / L Tween-20 (v / v), the solvent is water.

[0191] Washing reagent III components: 7.62 g / L Tris, 5.42 g / L sodium chloride, 0.35 mL / L Tween-20 (v / v), the solvent is water.

[0192] Washing reagent IV components: 8.7 g / L Tris, 7.37 g / L sodium chloride, and the solvent is water.

[0193] 1× PBS buffer (PH:7.2).

[0194] 1× PBST buffer (PH:7.2).

[0195] Step 1: 2 mL of PD-L1+ whole blood sample (the sample is the same as the PD-L1+ whole blood sample in Example 1) was centrifuged at 800 g for 10 min to obtain a plasma sample, which was placed in a 4°C refrigerator for use.

[0196] Step 2: Wash 50 μL (5 mg) of magnetic beads once with 1 mL of washing reagent I. Then add 900 μL of washing reagent I to resuspend, gradually add 30 μL (7 mg / mL) of SNSP-SA-NHS and 30 μL (3 mg / mL) of EDC, and react on a mixer for 30 min.

[0197] Step 3: Add 1 mL of washing reagent I and wash twice. Resuspend with 1 mL of washing reagent I and add 300 μg of anti-CD63 antibody. React on a mixer for 2-3 hours.

[0198] Step 4: Add 1 mL of washing reagent II to the test tube and wash once, wash once with 1 mL of washing reagent III, resuspend with 1 mL of washing reagent III, and place on a mixer overnight.

[0199] Step 5: Add 1 mL of washing reagent IV and wash three times, then resuspend with 1 mL of washing reagent IV to obtain magnetic beads-CD63 magnetic beads coupling reagent.

[0200] Step 6: Take 30 μL of magnetic bead-CD63 coupling reagent, add 1 mL of 1×PBST (PH: 7.2) buffer, blow and resuspend, place on a magnetic stand for magnetic separation, and remove the liquid phase after the solution is clarified. Prepare two 200 μL PD-L1+ plasma samples, add 352 μL of 1×PBS (PH7.2) buffer to each, and incubate at 37°C for 30 min.

[0201] Step 7: Add 1 mL of 1×PBST (PH7.2) buffer to each sample tube, resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice).

[0202] Step 8: Add 200 μL of exosome lysis reagent of group A and group B respectively, mix well by pipetting, let stand for 10 minutes, place on a magnetic stand for magnetic separation for 5 minutes, and then transfer the supernatant to a new centrifuge tube. Add 10 μL of magnetic beads-PD-L1 antibody 1 coupling reagent to the centrifuge tube, resuspend by pipetting, and incubate at room temperature for 20 minutes.

[0203] Step 9: Add 1mL 1×PBST (PH: 7.2) buffer and resuspend by pipetting, place on a magnetic stand for magnetic separation, remove the liquid phase after the solution is clarified, and repeat the operation once (wash twice). Add 250μL 1×PBST (PH: 7.2) buffer and 8μL AE-PD-L1 antibody 2 coupling reagent and resuspend by pipetting, and incubate at room temperature for 20min.

[0204] Step 10: Add 1 mL of 1×PBST (PH: 7.2) buffer and resuspend by pipetting. Place on a magnetic stand for magnetic separation. After the solution is clarified, remove the liquid phase and repeat the operation once (wash twice).

[0205] Step 11: Add 250 μL 1×PBST (PH: 7.2) buffer and resuspend by pipetting.

[0206] Step 12: Add 100 μL of excitation solution A, react for 3 min, then add 100 μL of excitation solution B, and detect the luminescence value of exosome PD-L1 protein at a wavelength of 430 nm. The data results of the detection are shown in Table 5. The data results in Table 5 show that both component A of the exosome lysis reagent and component B of the exosome lysis reagent can achieve good detection results.

[0207] Table 5

[0208]

[0209] The above are only some preferred embodiments of the present invention, and the present invention is not limited to the contents of the embodiments. For those skilled in the art, various changes and modifications can be made within the scope of the technical solution of the present invention, and any changes and modifications made are within the protection scope of the present invention.

Claims

1. An exosome lysis reagent, comprising: 3.47-4.35 g / L of tris(hydroxymethyl)aminomethane, 5.8-7.1 g / L of sodium chloride, 1-5% by volume of glycerol, 0.5-4% by volume of NP-40, 0.01-0.5 M of citrate, and the solvent is water.

2. The exosome lysis reagent according to claim 1, characterized in that: The lysis reagent includes 4.05 g / L tris(hydroxymethyl)aminomethane, 6.2 g / L sodium chloride, 2.5% glycerol, 1% NP-40, and 0.03 M citrate.

3. A kit for detecting exosomal PD-L1 protein, characterized in that: The kit comprises the exosome lysis reagent according to any one of claims 1 to 2.

4. The exosomal PD-L1 protein detection kit according to claim 3, characterized in that: The kit also includes: magnetic beads-CD63 coupling reagent, magnetic beads-PD-L1 antibody 1 coupling reagent, chemiluminescent marker-PD-L1 antibody 2 coupling reagent, and excitation solution.

5. The exosomal PD-L1 protein detection kit according to claim 4, characterized in that: The magnetic bead-CD63 coupling reagent includes: 8.2-9.15 g / L Tris, 6.05-7.88 g / L sodium chloride, 0.23-0.43 mg / mL magnetic bead-CD63 conjugate, wherein the concentration of antibody CD63 is 0.08-0.18 μg / mL, pH 7.5-8.0, and the solvent is water.

6. The exosomal PD-L1 protein detection kit according to claim 4, characterized in that: The magnetic bead-PD-L1 antibody 1 coupling reagent includes: 40-60 mM Tris; 0.4-0.6 M sodium chloride; 0.3-0.5 M sucrose; 3-5 g / L BSA, 0.51-0.63 mg / mL magnetic bead-PD-L1 antibody 1 conjugate, wherein the concentration of PD-L1 antibody 1 is 0.1-0.22 μg / mL, pH 7.5-8.0, and the solvent is water.

7. The exosomal PD-L1 protein detection kit according to claim 4, characterized in that: The chemiluminescent marker in the chemiluminescent marker-PD-L1 antibody 2 coupling reagent is AE, and the AE-PD-L1 coupling reagent includes: 4.5-7 g / L sodium dihydrogen phosphate, 3-4 g / L sodium dihydrogen phosphate, 5-7 g / L sodium chloride, 0.1-0.3 g / L Pluronic® F-127, 0.64-0.82 mg / mL AE-PD-L1 antibody 2 conjugate, pH 6.0-6.5, and the solvent is water.

8. The exosomal PD-L1 protein detection kit according to claim 4, characterized in that: The excitation liquid includes an excitation liquid A and an excitation liquid B, wherein the excitation liquid A includes 0.05-0.3% hydrogen peroxide and 0.28-0.5 M HNO3 by volume, and the solvent is water; the excitation liquid B includes 0.10-0.34 M sodium hydroxide and 0.2-1 mL / L Tween-20, and the solvent is water.

Citation Information

Patent Citations

  • Lysis solution for extracting animal virus ribonucleic acid (RNA)

    CN102505012A

  • Chemical luminescent detection kit of thyroglobulin and preparation method thereof

    CN107831163A

  • Improved immunohistochemical repairing solution

    CN108051582A

  • Method and apparatus for automated pre-treatment and processing of biological samples

    US20060134793A1

  • Lysis buffers for extracting nucleic acids

    US20180371449A1